Blog

The market expects Fortrea Holdings Inc. (FTRE) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known

Wall Street expects a year-over-year increase in earnings on higher revenues when Akoya Biosciences (AKYA) reports results for the quarter ended March 2025. While this widely-known consensus outlook

Duos Technologies Group, Inc. (DUOT) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known

The market expects Arcturus Therapeutics (ARCT) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known

Wall Street expects a year-over-year decline in earnings on higher revenues when AlTi Global, Inc. (ALTI) reports results for the quarter ended March 2025. While this widely-known consensus outlook

Wall Street expects a year-over-year decline in earnings on higher revenues when Agilysys (AGYS) reports results for the quarter ended March 2025. While this widely-known consensus outlook is

The market expects New Fortress Energy (NFE) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus

Wall Street expects a year-over-year increase in earnings on lower revenues when NRG Energy (NRG) reports results for the quarter ended March 2025. While this widely-known consensus outlook is

Wall Street expects a year-over-year increase in earnings on lower revenues when 3D Systems (DDD) reports results for the quarter ended March 2025. While this widely-known consensus outlook is

Wall Street expects a year-over-year decline in earnings on higher revenues when Fox Corporation (FOX) reports results for the quarter ended March 2025. While this widely-known consensus outlook is

HudBay Minerals (HBM) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook

HighPeak Energy, Inc. (HPK) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 5^th:

GeneDx Holdings Corp. WGS: This genomics-related diagnostic and information services

Fortinet FTNT is slated to report first-quarter 2025 results on May 7.For the first quarter of 2025, Fortinet expects revenues in the range of $1.5-$1.56 billion. It anticipates non-GAAP earnings

Marriott International, Inc. MAR is scheduled to release first-quarter 2025 results on May 6, before the opening bell. In the previous quarter, the company’s earnings beat the Zacks Consensus

Recently released economic data that shows a decline in March inflation and a jump in private payrolls has somewhat eased fears over the economy’s declining health. Also, President Donald Trump’s

Stagwell (STGW) closed the last trading session at $5.62, gaining 5.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Shares of Redwood Trust (RWT) have gained 10.1% over the past four weeks to close the last trading session at $5.89, but there could still be a solid upside left in the stock if short-term price

Veren (VRN) closed the last trading session at $5.92, gaining 7.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

LifeStance Health Group (LFST) closed the last trading session at $6.80, gaining 2.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

Howard Hughes Holdings (HHH) closed the last trading session at $67.47, gaining 0.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

Shares of First Majestic Silver (AG) have gained 5.9% over the past four weeks to close the last trading session at $5.91, but there could still be a solid upside left in the stock if short-term

Xenon Pharmaceuticals (XENE) closed the last trading session at $38.28, gaining 30.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

Triple Flag Precious Metals (TFPM) closed the last trading session at $20.94, gaining 13.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price

Pan American Silver (PAAS) closed the last trading session at $23.54, gaining 9.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by